Global Pharmaceutical Services (GPSI) inked an exclusive partnership with Abridge Clinical Research, an R&D firm located in Mumbai. The arrangement offers services that include CRO selection for a specific clinical program, monitoring of clinical studies, auditing, quality assurance, design and conduct of Phase I–IV clinical studies, patient enrollment, in-country sponsor representative, medical writing, data management, biostatistical services, and regulatory support.

NewsBiomanufacturingClinical developmentContract researchData managementDrug development (Pharmacology)Drug discoveryDrug research and developmentGenetic Engineering and BiotechnologyInformation managementInformation sciencePharmacologyTechnology and Computational Biology
Previous articleBiogen Idec Taps Evotec for Hit-Identification Research
Next articleInnate Pharma to Leverage French Research Through Alliance with Inserm
Also of Interest
Visual Proteomics: Observing Protein Location in Living Cells
Gene Network Interactions Shed Insight into Breast Cancer Onset and Development
Bruker to Acquire NanoString with $392.6M Winning Bid
At Bio-IT World 2024, AI Applications Take Center Stage
StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting
Launch of Nvelop Therapeutics for Delivery of Genetic Cargo, AACR Recap
Related Media
Boston and Bioprocessing: GEN Reports Live from the First Day at BPI
Excitement in Oakland: A Report from SynBioBeta
Celebrating DNA: Matthew Cobb's Reflections on the Double Helix
Emerging Markets Collaborate to Succeed in Post-Pandemic World
Breathing Oxygen Back into the Biological Conversation
Global Single-Use Network Support Assurance of Supply